Retour
Supreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech
Date du jugement25 mai 2023Autorité de délivranceSupreme People’s Court of the People’s Republic of ChinaDegré de l’autorité de délivranceInstance finaleType de procédureJudiciaire (civil)SujetConcurrence, Brevets (Inventions)Plaignant/AppelantYangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd; Yangtze River Pharmaceutical Group Co., Ltd.Défendeur/IntiméHefei Industrial Pharmaceutical Institute Co., Ltd; Hefei Enrite Pharmaceutical Co., Ltd.Mots-clés
Patent,
Abuse of dominant market position,
Restricting dealing,
Unfairly high price
Jugement/DécisionAnglaisSupreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTMLRésuméAnglaisSupreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTMLn° WIPO LexWIPOLEX016-j